Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

L'intersezione tra perdita di controllo alimentare e obesità: il ruolo della restrizione e del rinforzo alimentare

9 settembre 2026 aggiornato da: Katherine Balantekin, State University of New York at Buffalo

This study aims to determine the relationships among loss of control eating, restriction, relative reinforcing value of high energy-dense food, and obesity risk. In order to achieve this aim, the investigators will follow children over the course of a year, obtaining behavioral and observational measurements, in addition to a two-week restricted access and two week non-restricted access period.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The study will be mostly observational but will also include a randomized, cross-over design (the restricted access paradigm). The investigators will recruit children at risk for obesity in Erie County, New York (N=100, 50 boys, 50 girls). The study will include 4 visits at baseline and follow-up visits at 6 and 12 months. At the first visit, the participants will complete consent, height/weight/body fat, questionnaires, and complete a delayed discount task and the relative reinforcing value task. The participants will be randomized to have two weeks of restricted access first or two weeks of non-restricted access first, and then will come into the laboratory to do the loss of control test meal. Then they will have a one-week washout period, and will then complete the other two weeks of restricted/not restricted access. Following this, they will complete the loss of control test meal again. At the follow-up visits, participants will come into the laboratory to have their height/weight/body fat measured, complete questionnaires, and complete the delayed discounting task, food reinforcement and loss of control test meals. Participants will be compensated for their time after each visit. The details of the measures and procedures are outlined below.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

126

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • New York
      • Buffalo, New York, Stati Uniti, 14214
        • State University of New York at Buffalo, South Campus

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 8 anni a 11 anni (Bambino)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Children (male and female) ages 8-11
  • At risk for obesity or with obesity (defined as either having a BMI percentile that classifies the child as having overweight-BMI >85th percentile but <99th OR one + biological parent with overweight/obesity-BMI >25)
  • Rating of neutral or higher for 50% of the study foods
  • Consumption of one of the study foods at least twice/week

Exclusion Criteria:

  • Children below age 8 or above age 11
  • Not at risk for obesity (defined as having a BMI percentile that classifies the child as having normal weight-BMI <85th percentile without having a parent with overweight or obesity)
  • Allergic to study foods
  • Dislike of study foods (Less than 50% of the study foods rated neutral or higher)
  • Does not consume at least one study food at least twice/week
  • Current diagnosis of a clinical eating disorder (ED)
  • Use of medications known to affect appetite (Ritalin, Adderall, Concerta, Wellbutrin, Prednisone, etc)
  • Unwillingness to complete study visits

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Behavioral restriction first then structured intake

This arm reflects participants assigned to the restriction - first condition order. In the restriction period participants will have their preferred (chosen after doing a preference task, including liking) food and similar alternatives restricted by their parent for 2 weeks. In the structured intake period period, participants and their parents will be given several portions of the preferred food (chosen after doing a preference task, including liking) and will consume it throughout the two-week period.

In the restriction period participants will have their preferred (chosen after doing a preference task, including liking) food and similar alternatives restricted by their parent for 2 weeks.

In the structured intake period, participants and their parents will be given several portions of the preferred food (chosen after doing a preference task, including liking) and will consume it throughout the two-week period.

Sperimentale: Structured intake first then behavioral restriction

This arm reflects participants assigned to the structured intake - first condition order. In the structured intake period, participants and their parents will be given several portions of the preferred food (chosen after doing a preference task, including liking) and will consume it throughout the two-week period. In the restriction period participants will have their preferred (chosen after doing a preference task, including liking) food and similar alternatives restricted by their parent for 2 weeks.

In the restriction period participants will have their preferred (chosen after doing a preference task, including liking) food and similar alternatives restricted by their parent for 2 weeks.

In the structured intake period, participants and their parents will be given several portions of the preferred food (chosen after doing a preference task, including liking) and will consume it throughout the two-week period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Overall kcal and STUDY Food kcal Consumed After the Intervention Conditions (Behavioral Restriction and Structured Intake)
Lasso di tempo: Visit 3 (day 21) and visit 4 (day 42)

This measure examines the energy intake during test meal after BOTH paradigm conditions: behavioral restriction (2 weeks of restricted access to the STUDY food and similar items followed by a test meal) and structured intake (2 weeks to consume 8 provided portions of the STUDY food followed by a test meal). Conditions occurred between session 2 and session 3, and session 3 and session 4. All participants were exposed to both conditions, these conditions were randomized and there was a one week wash out period week between the two conditions.

Visit 3 (day 21) and visit 4 (day 42)
Overall Macronutrients Consumed After the Intervention Conditions (Behavioral Restriction and Structured Intake)
Lasso di tempo: Visit 3 (day 21) and visit 4 (day 42)

This measure examines the macronutrient intake during test meal after BOTH paradigm conditions: behavioral restriction (2 weeks of restricted access to the STUDY food and similar items followed by a test meal) and structured intake (2 weeks to consume 8 provided portions of the STUDY food followed by a test meal). Conditions occurred between session 2 and session 3, and session 3 and session 4. All participants were exposed to both conditions, these conditions were randomized and there was a one week wash out period week between the two conditions.

Visit 3 (day 21) and visit 4 (day 42)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Association Between the Logged Relative Reinforcing Value (RRV Log) of a High Energy Dense Food (Referred to as the STUDY Food) and Loss of Control (LOC)
Lasso di tempo: Session 1 (day 1) and Session 2 (day 7)

Relationships will be examined between the relative reinforcing value (RRV) of the STUDY food (which was measured at SESSION 1) and self-reported loss of control (LOC) eating (which was measured at the session 2 test meal; control test meal; no intervention occurred leading up to this test meal). RRV refers to how hard an individual is willing to work for a food and it is measured via the logged value of total responses (the logged value adjusts for skews). Scores range from 0 to 9.232. Higher values (worse outcome) indicate that an individual is willing to work harder (click longer) for their STUDY food. LOC eating was self - reported through a yes (value: 1; worse outcome) or no (value: 0; better outcome) question completed after the participant finished eating at the session 2 (control) test meal.

This outcome measure is focused on the survey data (thus, scores on a scale).

Session 1 (day 1) and Session 2 (day 7)
Association Between the Logged Relative Reinforcing Value (RRV Log) of a High Energy Dense Food (Referred to as the STUDY Food) and Loss of Control (LOC)
Lasso di tempo: Session 1 (day 1) and Session 2 (day 7)

Relationships will be examined between the relative reinforcing value (RRV) of the STUDY food (which was measured at SESSION 1) and self-reported loss of control (LOC) eating (which was measured at the SESSION 2 test meal; control test meal; no intervention occurred leading up to this test meal). RRV refers to how hard an individual is willing to work for a food and it is measured via the logged value of total responses (the logged value adjusts for skews). Scores range from 0 to 9.232. Higher values (worse outcome) indicate that an individual is willing to work harder (click longer) for their STUDY food. LOC eating was self - reported through a yes (value: 1; worse outcome) or no (value: 0; better outcome) question completed after the participant finished eating at the session 2 (control) test meal.

This outcome measure is focused on the RRV measure, with the unit of Log(Response), as it is measured using the logged value of total responses to adjust for skew.

Session 1 (day 1) and Session 2 (day 7)
Relationship Between Self-reported Loss of Control (LOC) Eating and Energy Intake During Session 2 (Control) Test Meal
Lasso di tempo: Session 2 (day 7)

Relationships between self-reported feelings of LOC after the session 2 test meal and energy intake during the session 2 test meal (control test meal; no intervention occurred leading up to this test meal) will be assessed. LOC eating was self - reported through a yes (value: 1; worse outcome) or no (value: 0; better outcome) question completed after the participant finished eating at the session 2 (control) test meal. .

Session 2 (day 7)
Relationship Between Self-reported Loss of Control (LOC) Eating and Macronutrient Intake During the Session 2 (Control) Test Meal
Lasso di tempo: Session 2 (day 7)

Relationships between self-reported feelings of LOC after the session 2 test meal and macronutrient intake during the session 2 test meal (control test meal; no intervention occurred leading up to this test meal) will be assessed. LOC eating was self - reported through a yes (value: 1; worse outcome) or no (value: 0; better outcome) question completed after the participant finished eating at the session 2 (control) test meal. These analyses will look at how self-reported feelings of LOC during the session 2 test meal predict macronutrient intake during that same test meal.

Session 2 (day 7)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Katherine Balantekin, PhD, RD, Clinical Associate Professor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

11 novembre 2021

Completamento primario (Effettivo)

22 maggio 2025

Completamento dello studio (Effettivo)

22 maggio 2025

Date di iscrizione allo studio

Primo inviato

10 dicembre 2021

Primo inviato che soddisfa i criteri di controllo qualità

29 dicembre 2021

Primo Inserito (Effettivo)

4 gennaio 2022

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

1 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • STUDY00002806
  • K01DK120778 (Sovvenzione/contratto NIH degli Stati Uniti)

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .